Localizing Antifungal Drugs to the Correct Organelle Can Markedly Enhance their Efficacy
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
A critical aspect of drug design is optimal target inhibition by specifically delivering the drug molecule not only to the target tissue or cell but also to its therapeutically active site within the cell. This study demonstrates, as a proof of principle, that drug efficacy can be increased considerably by a structural modification that targets it to the relevant organelle. Specifically, by varying the fluorescent dye segment an antifungal azole was directed from the fungal cell mitochondria to the endoplasmic reticulum (ER), the organelle that harbors the drug target. The ER‐localized azole displayed up to two orders of magnitude improved antifungal activity and also dramatically reduced the growth of drug‐tolerant fungal subpopulations in a panel of Candida species, which are the most prevalent causes of serious human fungal infections. The principle underlying the “target organelle localization” approach provides a new paradigm to improve drug potency and replenish the limited pipeline of antifungal drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to affecting resistance, drug uptake and efflux appears to contribute, at least partially, to tolerance9, based on studies with fluorescent azole probes and strains with similar MIC levels but different tolerance levels (measured as FoG and SMG, see Box ##)89,90”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [90]
Citations
Cites
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Global analysis of protein localization in budding yeast
Huh, W.-K., Falvo, J. V., Gerke, L. C., Carroll, A. S., Howson, R. W., Weissman, J. S., & O'Shea, E. K. (2003) · Nature · doi:10.1038/nature02026 · Cited by 4,248
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Ghannoum, M. A., & Rice, L. B. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.501 · Cited by 1,785
Antifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202
Current and emerging azole antifungal agents
Sheehan, D. J., Hitchcock, C. A., & Sibley, C. M. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.40 · Cited by 1,137
Emerging Frontiers in Drug Delivery
Tibbitt, M. W., Dahlman, J. E., & Langer, R. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09974 · Cited by 975
Discerning the Chemistry in Individual Organelles with Small‐Molecule Fluorescent Probes
Xu, W., Zeng, Z., Jiang, J., Chang, Y., & Yuan, L. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510721 · Cited by 808
Subcellular targeting strategies for drug design and delivery
Rajendran, L., Knölker, H.-J., & Simons, K. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2897 · Cited by 708
Biosynthesis of Cholesterol and Other Sterols
Nes, W. D. (2011) · Chemical Reviews · doi:10.1021/cr200021m · Cited by 633
Oral Azole Drugs as Systemic Antifungal Therapy
Wood, A. J. J., Como, J. A., & Dismukes, W. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300407 · Cited by 596
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576
Sterol 14α-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms
Lepesheva, G. I., & Waterman, M. R. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.07.018 · Cited by 474
Evolution of antifungal-drug resistance: mechanisms and pathogen fitness
Anderson, J. B. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1179 · Cited by 375
Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
Vincent, B. M., Lancaster, A. K., Scherz-Shouval, R., Whitesell, L., & Lindquist, S. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001692 · Cited by 322
Fungal Biofilms, Drug Resistance, and Recurrent Infection
Desai, J. V., Mitchell, A. P., & Andes, D. R. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019729 · Cited by 252
Ji, H., Zhang, W., Zhou, Y., Zhang, M., Zhu, J., Song, Y., Lü, J., & Zhu, J. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990589g · Cited by 213
Sagatova, A. A., Keniya, M. V., Wilson, R. K., Monk, B. C., & Tyndall, J. D. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00925-15 · Cited by 210
DiOC6 staining reveals organelle structure and dynamics in living yeast cells
Koning, A. J., Lum, P. Y., Williams, J. M., & Wright, R. (1993) · Cell Motility · doi:10.1002/cm.970250202 · Cited by 188
Metabolic response to iron deficiency in Saccharomyces cerevisiae
Shakoury-Elizeh, M., Protchenko, O., Berger, A., Cox, J., Gable, K., Dunn, T. M., Prinz, W. A., Bard, M., & Philpott, C. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091710 · Cited by 182
Global access to antifungal therapy and its variable cost
Kneale, M., Bartholomew, J. S., Davies, E., & Denning, D. W. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw325 · Cited by 175
The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review
Martin, M. V. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.4.429 · Cited by 150
Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery
Mateus, A., Gordon, L. J., Wayne, G. J., Almqvist, H., Axelsson, H., Seashore-Ludlow, B., Treyer, A., Matsson, P., Lundbäck, T., West, A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701848114 · Cited by 103
Ding, S., Qiao, X., Suryadi, J., Marrs, G. S., Kucera, G. L., & Bierbach, U. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201210079 · Cited by 88
Quantitating drug-target engagement in single cells in vitro and in vivo
Dubach, J. M., Kim, E., Yang, K., Cuccarese, M., Giedt, R. J., Meimetis, L. G., Vinegoni, C., & Weissleder, R. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2248 · Cited by 87
Breker, M., Gymrek, M., Moldavski, O., & Schuldiner, M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt933 · Cited by 83
Real-Time Imaging of the Azole Class of Antifungal Drugs in Live Candida Cells
Benhamou, R. I., Bibi, M., Steinbuch, K. B., Engel, H., Levin, M., Roichman, Y., Berman, J., & Fridman, M. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00339 · Cited by 71
Self-citationAdditional cassettes for epitope and fluorescent fusion proteins in Candida albicans
Gerami‐Nejad, M., Dulmage, K., & Berman, J. (2009) · Yeast · doi:10.1002/yea.1674 · Cited by 69
Self-citationWahrnehmung der chemischen Prozesse in einzelnen Organellen mit niedermolekularen Fluoreszenzsonden
Xu, W., Zeng, Z., Jiang, J., Chang, Y., & Yuan, L. (2016) · Angewandte Chemie · doi:10.1002/ange.201510721 · Cited by 68
The Subcellular Distribution of Small Molecules: From Pharmacokinetics to Synthetic Biology
Zheng, N., Tsai, H. N., Zhang, X., & Rosania, G. R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200092v · Cited by 67
Lee, H., Yang, Z., Wi, Y., Kim, T. W., Verwilst, P., Lee, Y. H., Han, G.-I., Kang, C., & Kim, J. S. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00508 · Cited by 56
Endosomes as a route for drug delivery in the real world
Sheff, D. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.11.005 · Cited by 33
Ding, S., Qiao, X., Suryadi, J., Marrs, G. S., Kucera, G. L., & Bierbach, U. (2013) · Angewandte Chemie · doi:10.1002/ange.201210079 · Cited by 27
Antifungal Imidazole‐Decorated Cationic Amphiphiles with Markedly Low Hemolytic Activity
Benhamou, R. I., Steinbuch, K. B., & Fridman, M. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201602198 · Cited by 25
Self-citationHuber, K. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2295 · Cited by 10
Research works printed but not linked: 2
- Anderson J. B., 2005, Nat. Rev., 3, 547
- Rosenberg A., 2017, BioRxiv Prepr.
Cited by
Drug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642
Self-citationA comprehensive overview of the medicinal chemistry of antifungal drugs: perspectives and promise
Howard, K. C., Dennis, E. K., Watt, D. S., & Garneau-Tsodikova, S. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00556k · Cited by 140
Bu, Y., Xu, T., Zhu, X., Zhang, J., Wang, L., Yu, Z., Yu, J., Wang, A., Tian, Y., Zhou, H., et al. (2020) · Chemical Science · doi:10.1039/d0sc03093g · Cited by 109
Elias, R., Benhamou, R. I., Jaber, Q. Z., Dorot, O., Zada, S. L., Oved, K., Pichinuk, E., & Fridman, M. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.003 · Cited by 78
Self-citationVitamin Biosynthesis as an Antifungal Target
Meir, Z., & Osherov, N. (2018) · Journal of Fungi · doi:10.3390/jof4020072 · Cited by 75
Metadata
- Authors
- Benhamou, R. I., Bibi, M., Berman, J., & Fridman, M.
- Affiliations
- Tel Aviv University (IL)
- Corresponding author
- Fridman, Micha
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2018-05-02
- Volume
- 57
- Issue
- 21
- Pages
- 6230-6235
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- PMC
- PMC7035955
- OpenAlex
- W2794039655
- Cited by
- 42
- References
- 35
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 7 · 2020: 6 · 2019: 7 · 2018: 5
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Angewandte Chemie International Edition (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Israel Science Foundation (6/14, 314/13)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
- Keywords
- antifungal agents, azole antifungals, endoplasmic reticulum localization, mitochondrial targeting, fluorescent dye conjugation, drug efficacy enhancement, Candida, drug resistance, structure-activity modification
- MeSH terms
- Antifungal Agents, Azoles, Candida, Microbial Sensitivity Tests, Drug Design, Organelles, Molecular Structure, Molecular Docking Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.